Resistance-associated amino acid variants associated with boceprevir plus pegylated interferon-α2b and ribavirin in patients with chronic hepatitis C in the SPRINT-1 trial
Robert A. Ogert, John A. Howe, John M. Vierling, Paul Y. Kwo, Eric J. Lawitz, Jonathan McCone, Eugene R. Schiff, David Pound, Mitchell N. Davis, Stuart C. Gordon, Natarajan Ravendhran, Lorenzo Rossaro, Ira M. Jacobson, Robert Ralston, Eirum Chaudhri, Ping Qiu, Lisa D. Pedicone, Clifford A. Brass, Janice K. Albrecht, Richard J O BarnardDaria J. Hazuda, Anita Y M Howe
Fingerprint
Dive into the research topics of 'Resistance-associated amino acid variants associated with boceprevir plus pegylated interferon-α2b and ribavirin in patients with chronic hepatitis C in the SPRINT-1 trial'. Together they form a unique fingerprint.